Patient Satisfaction and Sensory Attributes Allergic Rhinitis Nasal Spray

CompletedOBSERVATIONAL
Enrollment

426

Participants

Timeline

Start Date

November 8, 2021

Primary Completion Date

February 27, 2022

Study Completion Date

February 27, 2022

Conditions
Allergic Rhinitis
Interventions
OTHER

Observational

In this observational study, participants initated on RYALTRIS/DYMISTA nasal spray will complete a cross-sectional online survey that includes a Best-Worst Scaling task to capture their satisfaction and importance of various treatment attributes.

Trial Locations (1)

2000

Community and Patient Preference Research Pty Ltd, Sydney

Sponsors
All Listed Sponsors
collaborator

Seqirus

INDUSTRY

collaborator

Glenmark Pharmaceuticals S.A.

INDUSTRY

lead

Community and Patient Preference Research Pty Ltd

INDUSTRY

NCT05146206 - Patient Satisfaction and Sensory Attributes Allergic Rhinitis Nasal Spray | Biotech Hunter | Biotech Hunter